Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
Titel:
Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study
Auteur:
Kande Betu Ku Mesu, Victor Mutombo Kalonji, Wilfried Bardonneau, Clélia Valverde Mordt, Olaf Ngolo Tete, Digas Blesson, Séverine Simon, François Delhomme, Sophie Bernhard, Sonja Mahenzi Mbembo, Hélène Mpia Moke, Christian Lumeya Vuvu, Steven Mudji E'kitiak, Junior Akwaso Masa, Felix Mukendi Ilunga, Melchias Mpoyi Muamba Nzambi, Dieudonné Mayala Malu, Tim Kapongo Tshilumbwa, Serge Botalema Bolengi, Franck Nkieri Matsho, Mathieu Lumbala, Crispin Scherrer, Bruno Strub-Wourgaft, Nathalie Tarral, Antoine
Verschenen in:
The Lancet global health
Paginering:
Jaargang 9 () nr. 7 pagina's e999-e1008
Jaar:
2021
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license